Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-024815
Filing Date
2019-04-16
Accepted
2019-04-16 18:44:08
Documents
2
Period of Report
2019-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7498
2 POA DOCUMENT poa.txt EX-24.3_847911 3039
  Complete submission text file 0001209191-19-024815.txt   12147
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

EIN.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DR., STE. 225 SAN DIEGO CA 92121
Business Address
Cui Jingrong Jean (Reporting) CIK: 0001772259 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38871 | Film No.: 19751896